UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - therapeutics+%3e+transplant
5
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Surgical Mesh Permanent Implant (Case No. 2023-109)
Summary: UCLA Researchers in the Department of Chemistry and Biochemistry have developed a bacterial nanocellulose (BNC) that exhibits promising biocompatibility and mechanical properties that can be used as a long-term treatment for medical conditions requiring surgical mesh devices. Background: Surgical mesh devices are medical devices used to...
Published: 10/7/2024
|
Inventor(s):
Paul Weiss
,
Melina Mastrodimos
,
Maryam Badv
Keywords(s):
Biologic Medical Product
,
Biomedical Engineering
,
biomedical implantation
,
Implant (Medicine)
,
Medical Device
,
Medical Devices and Materials
,
Orthopedics and Prosthetics (O & P)
,
Prosthesis
,
Prosthetics
,
Smart medical device
,
Surgical Instrument
,
surgical mesh
,
Surgical Tools
,
wearable medical device
Category(s):
Medical Devices
,
Medical Devices > Surgical Tools
,
Materials
,
Materials > Functional Materials
,
Therapeutics
,
Therapeutics > Gastroenterology
,
Therapeutics > Urology
,
Therapeutics > Transplant
Method for Combined Conditioning and Chemoselection in a Single Cycle (UCLA Case No. 2011-478)
SUMMARY: Researchers at UCLA have developed a highly-efficient technique to engraft and select hematopoietic stem cells directly inside a patient. The invention will improve the fidelity of stem cell transplantations and reduce toxic side effects on patients. BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is a mainstay of treatment for...
Published: 11/15/2024
|
Inventor(s):
Gay Crooks
,
Robert Schiestl
,
Katrin Hacke
,
Akos Szakmary
Keywords(s):
blood cancers
,
Cancer stem cells
,
Hematopoietic stem cell transplantation
,
hematopoietic stem cells
,
lymphatic cancer
,
stem cell transplantations
,
Transplant
Category(s):
Therapeutics > Stem Cells And Regenerative Medicine
,
Therapeutics > Transplant
2011-896 Protein Biomarkers for Immune Assessment and Prediction of Transplant Rejection
Background Current diagnostic methods of renal allograft rejection are neither sensitive, nor specific. Needle biopsies are invasive and associated with patient morbidity. It is thus desirable to develop noninvasive tests to predict and diagnose rejection. Innovation UCLA researchers have identified a number of proteins present in human plasma associated...
Published: 7/19/2023
|
Inventor(s):
Keywords(s):
Category(s):
Therapeutics > Transplant
2008-369 Fungal Immunosuppressive Compounds
Summary UCLA inventors have discovered a novel compound from a fungus that would have broad applicability for the treatment of human autoimmune diseases and transplantation rejection. Background Endophytes, microorganisms that reside in the tissues of living plants, are relatively unstudied and potential sources of novel natural products for exploitation...
Published: 9/20/2023
|
Inventor(s):
Keywords(s):
Category(s):
Therapeutics > Transplant
2012-292 Organ Resuscitation Solution & System for Enhanced Liver Transplantation
Summary Background Liver organs suffer a tremendous degree of ischemia and reperfusion injury (IRI) during transplantation. The injury stems from the interruption of blood flow and depletion of nutrients to the organ in the period between donor organ procurement, preservation and transplantation into the recipient. Cell injury or death and metabolic...
Published: 7/19/2023
|
Inventor(s):
Keywords(s):
Category(s):
Therapeutics > Transplant